FDA-Drug2023-04-12Class II

Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

RemedyRepack Inc.
Hazard

cGMP Deviations

Sold states
RemedyRepack distributed product to consignees nationwide within the United States
Affected count
a) 58 bottles, b) 6 bottles
Manufactured in
625 Kolter Dr Ste 4, Indiana, PA, United States
Products
Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0492-2023

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief